An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with Schizophrenia
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with Schizophrenia
Authors
Keywords
-
Journal
Clinical Psychopharmacology and Neuroscience
Volume 13, Issue 1, Pages 62-67
Publisher
Korean College of Neuropsychopharmacology
Online
2015-04-23
DOI
10.9758/cpn.2015.13.1.62
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Test-Retest Reliability of Four Computerized Neurocognitive Assessment Tools in an Active Duty Military Population
- (2013) W. R. Cole et al. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY
- Three-Month Stability of the CogState Brief Battery in Healthy Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease: Results from the Australian Imaging, Biomarkers, and Lifestyle-Rate of Change Substudy (AIBL-ROCS)
- (2013) Y. Y. Lim et al. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY
- Effects of raloxifene on cognition in postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial
- (2013) Elena Huerta-Ramos et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Clinical symptoms and cognitive impairment associated with male schizophrenia relate to plasma manganese superoxide dismutase activity: A case-control study
- (2013) Xiang Yang Zhang et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Mitochondrial activity and oxidative stress markers in peripheral blood mononuclear cells of patients with bipolar disorder, schizophrenia, and healthy subjects
- (2013) Carolina Gubert et al. JOURNAL OF PSYCHIATRIC RESEARCH
- A Randomized Exploratory Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) for Cognitive Enhancement in Schizophrenia
- (2013) Jeffrey A Lieberman et al. NEUROPSYCHOPHARMACOLOGY
- Cognition impairment in schizophrenia patients with tardive dyskinesia: Association with plasma superoxide dismutase activity
- (2013) Jing Qin Wu et al. SCHIZOPHRENIA RESEARCH
- Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia
- (2013) Junji Saruwatari et al. Neuropsychiatric Disease and Treatment
- Neural Basis for the Ability of Atypical Antipsychotic Drugs to Improve Cognition in Schizophrenia
- (2013) Tomiki Sumiyoshi et al. Frontiers in Behavioral Neuroscience
- Add-on Treatment of Benzoate for Schizophrenia
- (2013) Hsien-Yuan Lane et al. JAMA Psychiatry
- Intraindividual cognitive decline using a brief computerized cognitive screening test
- (2012) David G. Darby et al. Alzheimers & Dementia
- Treating Impaired Cognition in Schizophrenia
- (2012) H. M. Ibrahim et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Sigma-1 Receptor Agonists as Therapeutic Drugs for Cognitive Impairment in Neuropsychiatric Diseases
- (2012) Tomihisa Niitsu et al. CURRENT PHARMACEUTICAL DESIGN
- Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study
- (2012) Yen Ying Lim et al. JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY
- A Randomized, Double-Blind, Placebo-Controlled Trial of Fluvoxamine in Patients With Schizophrenia
- (2012) Tomihisa Niitsu et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Is Altered BDNF Biosynthesis a General Feature in Patients with Cognitive Dysfunctions?
- (2012) Davide Carlino et al. NEUROSCIENTIST
- Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder
- (2012) Taisuke Yoshida et al. PLoS One
- Sigma-1 receptor chaperone and brain-derived neurotrophic factor: Emerging links between cardiovascular disease and depression
- (2012) Kenji Hashimoto PROGRESS IN NEUROBIOLOGY
- Plasma total antioxidant status and cognitive impairments in schizophrenia
- (2012) Xiang Yang Zhang et al. SCHIZOPHRENIA RESEARCH
- Computerized cognitive remediation training for schizophrenia: An open label, multi-site, multinational methodology study
- (2012) N.V. Murthy et al. SCHIZOPHRENIA RESEARCH
- A preliminary, randomized, double-blind, placebo-controlled trial of l-carnosine to improve cognition in schizophrenia
- (2012) K.N. Roy Chengappa et al. SCHIZOPHRENIA RESEARCH
- A Review of Brain-derived Neurotrophic Factor as a Candidate Biomarker in Schizophrenia
- (2012) Milawaty Nurjono et al. Clinical Psychopharmacology and Neuroscience
- Effects of the Antioxidant Sulforaphane on Hyperlocomotion and Prepulse Inhibition Deficits in Mice after Phencyclidine Administration
- (2012) Yumi Shirai et al. Clinical Psychopharmacology and Neuroscience
- Reliability of Repeated Cognitive Assessment of Dementia Using a Brief Computerized Battery
- (2011) Dustin Hammers et al. American Journal of Alzheimers Disease and Other Dementias
- Sulforaphane protects SK-N-SH cells against antipsychotic-induced oxidative stress
- (2011) Sergi Mas et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Criterion and Construct Validity of the CogState Schizophrenia Battery in Japanese Patients with Schizophrenia
- (2011) Taisuke Yoshida et al. PLoS One
- Protective effects of the antioxidant sulforaphane on behavioral changes and neurotoxicity in mice after the administration of methamphetamine
- (2011) Hongxian Chen et al. PSYCHOPHARMACOLOGY
- Clinical Trials of Potential Cognitive-Enhancing Drugs in Schizophrenia: What Have We Learned So Far?
- (2011) Richard S. E. Keefe et al. SCHIZOPHRENIA BULLETIN
- Cognition in schizophrenia: core psychological and neural mechanisms
- (2011) Deanna M. Barch et al. TRENDS IN COGNITIVE SCIENCES
- Antioxidant Therapeutics for Schizophrenia
- (2010) Ravinder Reddy et al. ANTIOXIDANTS & REDOX SIGNALING
- Antioxidants, Redox Signaling, and Pathophysiology in Schizophrenia: An Integrative View
- (2010) Jeffrey K. Yao et al. ANTIOXIDANTS & REDOX SIGNALING
- Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis
- (2010) M J Green et al. MOLECULAR PSYCHIATRY
- Assessment of Cognitive Function Before and After Surgery for Posterior Cranial Fossa Lesions Using Computerized and Conventional Tests
- (2010) Shinya ICHIMURA et al. NEUROLOGIA MEDICO-CHIRURGICA
- Oxidative stress in schizophrenia: An integrated approach
- (2010) Byron K.Y. Bitanihirwe et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Brain-derived neurotrophic factor as a biomarker for mood disorders: An historical overview and future directions
- (2010) Kenji Hashimoto PSYCHIATRY AND CLINICAL NEUROSCIENCES
- A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
- (2010) Akihiro Shiina et al. Annals of General Psychiatry
- Validity of the CogState Brief Battery: Relationship to Standardized Tests and Sensitivity to Cognitive Impairment in Mild Traumatic Brain Injury, Schizophrenia, and AIDS Dementia Complex
- (2009) P. Maruff et al. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY
- A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia
- (2009) Robert H. Pietrzak et al. JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY
- Evaluation of the Usability of a Brief Computerized Cognitive Screening Test in Older People for Epidemiological Studies
- (2009) J. Fredrickson et al. NEUROEPIDEMIOLOGY
- Status of computerized cognitive testing in aging: A systematic review
- (2008) Katherine Wild et al. Alzheimers & Dementia
- The MATRICS Consensus Cognitive Battery, Part 2: Co-Norming and Standardization
- (2008) Robert S. Kern et al. AMERICAN JOURNAL OF PSYCHIATRY
- The MATRICS Consensus Cognitive Battery, Part 1: Test Selection, Reliability, and Validity
- (2008) Keith H. Nuechterlein et al. AMERICAN JOURNAL OF PSYCHIATRY
- N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial
- (2008) Michael Berk et al. BIOLOGICAL PSYCHIATRY
- Stability of cognitive impairment in chronic schizophrenia over brief and intermediate re-test intervals
- (2008) Robert H. Pietrzak et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Partial compliance in schizophrenia and the impact on patient outcomes
- (2008) Pierre-Michel Llorca PSYCHIATRY RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now